Cargando…
Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications
Non-alcoholic fatty liver disease (NAFLD) is the most common liver pathology in the western countries. Psoriatic patients are at higher risk of having NAFLD, and at higher risk of experiencing a more severe form of the disease with poorer outcomes. The components of the metabolic syndrome – obesity,...
Autores principales: | Klujszo, Elzbieta H., Parcheta, Piotr, Witkowska, Anna B., Krecisz, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507165/ https://www.ncbi.nlm.nih.gov/pubmed/32994765 http://dx.doi.org/10.5114/ada.2019.83983 |
Ejemplares similares
-
Relationship between psoriasis and non-alcoholic fatty liver disease
por: Narayanasamy, Krishnasamy, et al.
Publicado: (2016) -
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
por: Tana, Claudio, et al.
Publicado: (2019) -
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018) -
Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies
por: Zhang, Han, et al.
Publicado: (2021) -
Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells
por: Michalska, Anna, et al.
Publicado: (2020)